about
High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity.Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.Heparan sulfates and the decrease of N-glycans promote early adipogenic differentiation rather than myogenesis of murine myogenic progenitor cells.Increased signaling by the autism-related Engrailed-2 protein enhances dendritic branching and spine density, alters synaptic structural matching, and exaggerates protein synthesis.In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.[Heparan sulphates, amyloidosis and neurodegeneration].New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β.New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitorsSLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defectsThe role of heparan sulfates in protein aggregation and their potential impact on neurodegenerationSmall, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresisPremature atherosclerosis is not systematic in phytosterolemic patients: Severe hypercholesterolemia as a confounding factor in five subjectsMetabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activityPreferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles
P50
Q34493756-DB69E86A-8275-458E-B73D-C979EAE7D595Q34758389-61072E5F-26EF-4991-8BBE-6D984ED54756Q39334663-A117FF8E-5E30-49ED-BA3C-BD238932BAC1Q41410549-9615553D-0165-4665-9317-F2C79B482E89Q42676530-8C872E43-B290-4745-9470-853F066E9E61Q43275080-9364C8B9-B645-4411-AA0F-1DB86D9D099CQ44550492-784229B8-6FAF-451F-BABB-5F55049D6C1FQ44739004-4694AD26-562A-45DF-A270-7C86854BC6BBQ45281586-0CB35594-8298-40D4-BB27-5072AB35B815Q46700747-D4BA6CDB-F5EF-40BD-A935-11911B4E9805Q47390287-0690F058-33E4-47B0-98BE-9F41AB1F2A93Q48246914-E42F7D05-D8DA-45B1-A6C6-33FC3D35D87AQ50052436-8ABBF088-2FC5-4440-8979-6D0366608623Q53598357-08825C15-98D5-4572-8BD2-AE9DA9E4098CQ56833662-D7BDD6C0-D68B-484D-A73A-34311173615BQ58063397-C9EDA957-4F92-4C16-B681-3785C62CD77FQ58063401-02B91473-5499-4C3A-87ED-80B6103E698BQ58063428-655321E4-ADF1-4DC1-B422-18F4020D2F70Q58063441-459C1822-18EC-4B03-ADBA-5B886796836BQ58063473-6CBAD1A0-B7FF-4410-816B-6639A6D6600FQ58063479-2E2F8F4D-1CB7-4A4A-9BEB-292F9A7A3730
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Sandrine CHANTEPIE
@ast
Sandrine CHANTEPIE
@en
Sandrine CHANTEPIE
@es
Sandrine CHANTEPIE
@nl
type
label
Sandrine CHANTEPIE
@ast
Sandrine CHANTEPIE
@en
Sandrine CHANTEPIE
@es
Sandrine CHANTEPIE
@nl
prefLabel
Sandrine CHANTEPIE
@ast
Sandrine CHANTEPIE
@en
Sandrine CHANTEPIE
@es
Sandrine CHANTEPIE
@nl
P106
P21
P31
P496
0000-0003-1652-432X